Latest News

Findings point toward one of first therapies for Lou Gehrig's disease

Researchers have determined that a copper compound known for decades may form the basis for a therapy for amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. In humans, prior to this, no therapy for ALS has ever been discovered that could extend lifespan more than a few additional months.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Vitamin D deficiency increases poor brain function after cardiac arrest by sevenfold

  • I have anxiety, why is my doctor prescribing an antipsychotic? New drug naming system unveiled

  • Women more likely to develop anxiety and depression after heart attack

  • Gene duplications associated with autism evolved recently in human history

  • Research reveals likelihood, onset of multiple sclerosis diagnosis among patients with inflammatory eye disease

  • Eating breakfast increases brain chemical involved in regulating food intake, cravings

  • Using feminist theory to understand male rape

  • YouTube as peer support for severe mental illness

  • Women driven by status, wealth rather than wanting babies, study suggests

  • Change your walking style, change your mood

  •